Cartas al Director
Experiencia inicial con aflibercept intravítreo en la degeneración macular asociada a la edad exudativa refractaria al tratamiento con ranibizumab o bevacizumab
Initial experience with aflibercept in the management of patients with wet age-related macular degeneration refractory to ranibizumab and/or bevacizumab
R.E. Cervera
, V. Castro, J. Montero, C. Torralba, A. Gracia
Autor para correspondencia
Servicio de Oftalmología, Hospital General Universitario, Valencia, España
Leído
1695
Vecesse ha leído el artículo
366
Total PDF
1329
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2020 6 | 1 | 0 | 1 |
| 2019 6 | 1 | 0 | 1 |
| 2018 5 | 1 | 0 | 1 |
| 2018 2 | 18 | 0 | 18 |
| 2018 1 | 32 | 1 | 33 |
| 2017 12 | 18 | 3 | 21 |
| 2017 11 | 42 | 3 | 45 |
| 2017 10 | 25 | 3 | 28 |
| 2017 9 | 10 | 2 | 12 |
| 2017 8 | 17 | 0 | 17 |
| 2017 7 | 25 | 1 | 26 |
| 2017 6 | 43 | 3 | 46 |
| 2017 5 | 53 | 7 | 60 |
| 2017 4 | 30 | 14 | 44 |
| 2017 3 | 30 | 27 | 57 |
| 2017 2 | 19 | 2 | 21 |
| 2016 1 | 16 | 4 | 20 |
| 2016 12 | 49 | 4 | 53 |
| 2016 11 | 35 | 4 | 39 |
| 2016 10 | 52 | 5 | 57 |
| 2016 9 | 45 | 8 | 53 |
| 2016 8 | 19 | 2 | 21 |
| 2016 7 | 27 | 6 | 33 |
| 2016 6 | 35 | 17 | 52 |
| 2016 5 | 25 | 11 | 36 |
| 2016 4 | 18 | 22 | 40 |
| 2016 3 | 32 | 5 | 37 |
| 2016 2 | 33 | 8 | 41 |
| 2015 1 | 15 | 11 | 26 |
| 2015 12 | 36 | 14 | 50 |
| 2015 11 | 39 | 9 | 48 |
| 2015 10 | 41 | 13 | 54 |
| 2015 9 | 20 | 3 | 23 |
| 2015 8 | 30 | 7 | 37 |
| 2015 7 | 17 | 5 | 22 |
| 2015 6 | 16 | 5 | 21 |
| 2015 5 | 28 | 17 | 45 |
| 2015 4 | 22 | 14 | 36 |
| 2015 3 | 23 | 20 | 43 |
| 2015 2 | 33 | 6 | 39 |
| 2015 1 | 24 | 7 | 31 |
| 2014 12 | 34 | 13 | 47 |
| 2014 11 | 37 | 11 | 48 |
| 2014 10 | 35 | 10 | 45 |
| 2014 9 | 39 | 6 | 45 |
| 2014 8 | 32 | 10 | 42 |
| 2014 7 | 45 | 18 | 63 |
| 2014 5 | 4 | 0 | 4 |
| 2014 3 | 1 | 3 | 4 |
| 2014 2 | 7 | 1 | 8 |
| 2014 1 | 0 | 1 | 1 |
Mostrar todo
